002437 誉衡药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.86812.8867.308-16.5272.408
总资产报酬率 ROA (%)8.3277.7883.330-6.6440.978
投入资产回报率 ROIC (%)11.38710.5484.311-8.5251.291

边际利润分析
销售毛利率 (%)46.41953.46058.38956.92557.528
营业利润率 (%)15.93111.6716.666-8.6903.049
息税前利润/营业总收入 (%)16.14411.5797.924-7.1735.000
净利润/营业总收入 (%)14.8909.9374.901-9.3151.712

收益指标分析
经营活动净收益/利润总额(%)74.71678.23277.354-22.98754.757
价值变动净收益/利润总额(%)13.784-3.077-23.40499.959-10.831
营业外收支净额/利润总额(%)1.515-0.4090.979-0.151-11.540

偿债能力分析
流动比率 (X)1.3911.0660.8180.7770.822
速动比率 (X)1.2060.8370.6830.6860.690
资产负债率 (%)28.12530.16745.74958.18757.852
带息债务/全部投入资本 (%)3.7551.62029.48547.66147.104
股东权益/带息债务 (%)2,531.9995,981.618234.766107.551110.091
股东权益/负债合计 (%)253.132228.885115.22368.81069.737
利息保障倍数 (X)-508.696-264.7006.646-4.7692.206

营运能力分析
应收账款周转天数 (天)18.78024.34629.73726.27331.902
存货周转天数 (天)51.69460.11166.68276.13197.426